Literature DB >> 8042857

beta-Amyloid formation as a potential therapeutic target for Alzheimer's disease.

B Cordell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042857     DOI: 10.1146/annurev.pa.34.040194.000441

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  8 in total

1.  Cellular distribution of gamma-secretase subunit nicastrin in the developing and adult rat brains.

Authors:  A Kodam; K S Vetrivel; G Thinakaran; S Kar
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

Review 2.  Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.

Authors:  A Pascale; S Govoni; F Battaini
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

Review 3.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 4.  Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.

Authors:  C M VanDenBerg; Y Kazmi; M W Jann
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

5.  Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates.

Authors:  G D Fasman; A Perczel; C D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

6.  Prostaglandin E2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants.

Authors:  R K Lee; S Knapp; R J Wurtman
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

7.  Inflammation and the pathophysiology of Alzheimer's disease.

Authors:  M M Greer
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

8.  Brain areas involved in the acupuncture treatment of AD model rats: a PET study.

Authors:  Yangjia Lu; Yong Huang; Chunzhi Tang; Baoci Shan; Shaoyang Cui; Junjun Yang; Junqi Chen; Renyong Lin; Huiling Xiao; Shanshan Qu; Xinsheng Lai
Journal:  BMC Complement Altern Med       Date:  2014-05-31       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.